Articles By Anuja Singh
Are Galux and Boehringer Ingelheim Pioneering AI in Precision Protein Design?
December 17, 2025 — Galux, a South Korean biotech company focused on AI-driven protein therapeutics, has entered a…
ByHas the FDA Approval of Breyanzi Expanded CAR T Cell Therapy Options for Marginal…
Bristol Myers Squibb has received approval from the U.S. Food and Drug Administration for Breyanzi, a CD19-directed CAR…
Does a New Kidney Cancer Trial Expand Long-Term Oncology Optionality for Bristol-Myers Squibb and…
December 2025 — Bristol-Myers Squibb and BioNTech have announced progress in their oncology collaboration with the initiation of…
Is Gilead’s Experimental HIV Treatment Matching the Efficacy of Its Blockbuster Drug in Late-Stage…
Foster City, California — Gilead Sciences has reported that its experimental HIV treatment has met the primary goal…
Is the White House (Trump) Expanding Its Drug Price Reduction Strategy with the Largest…
Washington, D.C. — The U.S. administration has announced a new set of agreements with nine pharmaceutical companies to…
Is Sanofi Strengthening Its Alzheimer’s Pipeline with a $1.04 Billion Partnership with South Korea’s…
Paris – Sanofi, the global pharmaceutical company, has announced a strategic collaboration with South Korea-based biotech ADEL to…
Are Galux and Boehringer Ingelheim Pioneering AI in Precision Protein Design?
December 17, 2025 — Galux, a South Korean biotech company focused on AI-driven protein therapeutics, has entered a…
Has the FDA Approval of Breyanzi Expanded CAR T Cell Therapy Options for Marginal…
Bristol Myers Squibb has received approval from the U.S. Food and Drug Administration for Breyanzi, a CD19-directed CAR…
Does a New Kidney Cancer Trial Expand Long-Term Oncology Optionality for Bristol-Myers Squibb and…
December 2025 — Bristol-Myers Squibb and BioNTech have announced progress in their oncology collaboration with the initiation of…
Is Gilead’s Experimental HIV Treatment Matching the Efficacy of Its Blockbuster Drug in Late-Stage…
Foster City, California — Gilead Sciences has reported that its experimental HIV treatment has met the primary goal…
Is the White House (Trump) Expanding Its Drug Price Reduction Strategy with the Largest…
Washington, D.C. — The U.S. administration has announced a new set of agreements with nine pharmaceutical companies to…
Is Sanofi Strengthening Its Alzheimer’s Pipeline with a $1.04 Billion Partnership with South Korea’s…
Paris – Sanofi, the global pharmaceutical company, has announced a strategic collaboration with South Korea-based biotech ADEL to…